Evidence map›Paper›PMID 35927749›Full record

ArticleImmunity & ageing : I & A2022

Novel approach to analysis of the immune system using an ungated model of immune surface marker abundance to predict health outcomes.

G Provost, F B Lavoie, A Larbi, T P Ng, C Tan Tze Ying, M Chua, T Fulop, A A Cohen

Abstract read
In one paragraph

Article in Immunity & ageing : I & A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

G ProvostGroupe de recherche PRIMUS, Department of Family Medicine, University of Sherbrooke, 3001 12e Ave N, QC, J1H 5N4, Sherbrooke, Canada.
F B LavoieGroupe de recherche PRIMUS, Department of Family Medicine, University of Sherbrooke, 3001 12e Ave N, QC, J1H 5N4, Sherbrooke, Canada.
A LarbiSingapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, Biopolis, Singapore, Singapore.
T P NgGerontology Research Programme, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore, Singapore.
C Tan Tze YingSingapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, Biopolis, Singapore, Singapore.
M ChuaSingapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, Biopolis, Singapore, Singapore.
T FulopResearch Center on Aging, Geriatric Division, Department of Medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC, Sherbrooke, Canada.
A A CohenGroupe de recherche PRIMUS, Department of Family Medicine, University of Sherbrooke, 3001 12e Ave N, QC, J1H 5N4, Sherbrooke, Canada. Alan.Cohen@USherbrooke.ca.

Funding

Biomedical Research Council BMRC/08/1/21/19/567CIHR 106634Fonds de Recherche du Québec - Santé 2020/AUDC/270433National Medical Research Council NMRC/1108/2007National Science and Engineering Research Council RGPIN-2018-06096
6 · The paper itself

Abstract

Traditionally, the immune system is understood to be divided into discrete cell types that are identified via surface markers. While some cell type distinctions are no doubt discrete, others may in fact vary on a continum, and even within discrete types, differences in surface marker abundance could have functional implications. Here we propose a new way of looking at immune data, which is by looking directly at the values of the surface markers without dividing the cells into different subtypes. To assess the merit of this approach, we compared it with manual gating using cytometry data from the Singapore Longitudinal Aging Study (SLAS) database. We used two different neural networks (one for each method) to predict the presence of several health conditions. We found that the model built using raw surface marker abundance outperformed the manual gating one and we were able to identify some markers that contributed more to the predictions. This study is intended as a brief proof-of-concept and was not designed to predict health outcomes in an applied setting; nonetheless, it demonstrates that alternative methods to understand the structure of immune variation hold substantial progress.

Indexed as

Complex systemImmunologyNeural network

Identifiers

PMID35927749
PMCPMC9351261

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.